Jubilant HollisterStier, a CDMO unit of Singapore’s Jubilant Pharma, plans to spend (PDF) $76 million to expand its Montreal facility. The project will double the plant’s drug production capacity.
The project will include adding specialized equipment and a new single-use sterile preparation room to maximize the filling process linked to the production of liquid sterile products, the company said. Other details of the project, such as size and date of completion, weren’t disclosed.
The government of Quebec has granted the company a $19 million loan toward the project, of which $4.8 million is forgivable.
Jubilant HollisterStier, which is based in Spokane, Washington, has been ramping up its sterile injectables manufacturing capacity in the wake of the COVID-19 pandemic.
In late May, the company hauled in a contract from the U.S. government worth $146.6 million that will allow the CDMO to double its injectables filling capacity in Spokane. The expansion will cost a total of $193 million.